UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell ...

Vadodara: Sun Pharmaceutical Industries Limited's investee company, Lyndra Therapeutics Inc., has ceased operations due to ...

Sun Pharma shares dipped in the intraday trading session on Friday, March 28. The Indian equity markets are in a tight spot, ...

The 30-share BSE Sensex dropped 144.66 points to 77,461.77 in early trading, while the NSE Nifty slipped 38.7 points to 23,553.25. Among the Sensex constituents, Mahindra & Mahindra, Infosys, Power ...

Ohioans who purchased certain generic drugs between 2009 and 2019 may be able to get a piece of a $49.1 million settlement following a decade-long price-fixing scheme. Two drug makers accused of ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

U.S. President Trump imposes 25% tariff on auto imports, spotlight on pharma imports, Indian industry at risk.

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Some of the top gainers during today’s session were Bajaj Finserv, IndusInd Bank, NTPC, L&T, Ultratech Cement, Hero MotoCorp, ...

Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports. The Nifty Pharma Index dropped 1.5%, with J B Chemicals & Pharmaceuticals ...

Lyndra Therapeutics Inc ceases operations due to funding issues, despite strategic investment from Sun Pharma in 2023.

Detailed price information for Cosmo Pharmaceuticals NV (CMOPF) from The Globe and Mail including charting and trades.